Similar articles

• Differential sensitivity to neuroleptic drugs of cerebral dopamine receptors following chronic treatment of rats with trifluoperazine.

  Dawbarn D, Pycock C. Dawbarn D, et al. Eur J Pharmacol. 1981 May 8;71(2-3):233-45. doi: 10.1016/0014-2999(81)90026-1. Eur J Pharmacol. 1981. PMID: 6113967 No abstract available.
• Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatum.

  Murugaiah K, Theodorou A, Mann S, Clow A, Jenner P, Marsden CD. Murugaiah K, et al. Nature. 1982 Apr 8;296(5857):570-2. doi: 10.1038/296570a0. Nature. 1982. PMID: 6122161 No abstract available.
• The residual effect of chronic neuroleptic treatment on the neuroleptic binding assay in rats.

  Wan CW, Peck EJ Jr, Ho BT, Schoolar JC. Wan CW, et al. Life Sci. 1983 Mar 14;32(11):1255-62. doi: 10.1016/0024-3205(83)90195-9. Life Sci. 1983. PMID: 6834989
• Effect of repeated administration of U-50,488H on the binding of 3H-SCH 23390 and 3H-spiperone to rat brain and spinal cord dopamine receptors.

  Bhargava HN, Ramarao P, Gulati A. Bhargava HN, et al. Prog Clin Biol Res. 1990;328:153-6. Prog Clin Biol Res. 1990. PMID: 2406759 No abstract available.
• Central nervous system dopamine receptors.

  Creese I. Creese I. Adv Biochem Psychopharmacol. 1980;21:235-42. Adv Biochem Psychopharmacol. 1980. PMID: 6103649 Review. No abstract available.